2034 - Personalized Circulating Tumor DNA Predicts Risk of Recurrence after Tri-Modality Therapy in Esophageal Squamous Cell Carcinoma Patients Achieving Pathologic Complete Response

03:00pm - 04:00pm ET

Presenter(s)

Jason Chia-Hsien Cheng, MD, PhD, MS, FASTRO - National Taiwan University Hospital, Taipei, Taipei